🔎 Trials Near Me

Dachaigh › Galaran sgamhain eadar-fhillte › Kansas › Kansas City

Sgrùdaidhean clionaigeach Galaran sgamhain eadar-fhillte ann an Kansas City, KS

Tha 13 sgrùdaidhean airson Galaran sgamhain eadar-fhillte a’ lorg phàirtichean aig làraichean ann agus timcheall air Kansas City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

A’ fastadhÌre 3
  • University of Kansas Medical Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

A’ fastadhÌre 3
  • University of Kansas Medical Center, Kansas City
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

A’ fastadhÌre 3
  • USA002, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07179380

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

A’ fastadhÌre 2
  • University of Kansas Medical Center, Kansas City
Aoisean 40 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06968845

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

A’ fastadhÌre 2
  • Clinical Research Site, Kansas City
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

A’ fastadhSgrùdadh amharc
  • University of Kansas Medical Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

A’ fastadhÌre 2
  • University of Kansas School of Medicine, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A’ fastadhÌre 2/3
  • University of Kansas Medical Center, Kansas City
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06328777

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

A’ fastadhÌre 2
  • The University of Kansas Medical Center Research Institute, Kansas City
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

A’ fastadhÌre 3
  • University of Kansas Medical Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT05943535

Interstitial Lung Disease Research Unit Biobank

A’ fastadhSgrùdadh amharc
  • The University of Kansas Medical Center, Kansas City
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05392881

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
  • University of Kansas Medical Center, Kansas City
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT04624490

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

A’ fastadhSgrùdadh amharc
  • University of Kansas, Kansas City
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 3 Cèit 2024 · NCT06397677

Sgrùdaidhean Galaran sgamhain eadar-fhillte ann am bailtean eile

Sgrùdaidhean eile ann an Kansas City

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.